The toll-like receptor 1 variant S248N influences placental malaria

Infection, Genetics and Evolution

Volumn 10, Issue 6, 2010, Pages 785-789

  Hamann, Lutz ^a   Bedu Addo, George ^b   Eggelte, Teunis A ^c   Schumann, Ralf R ^a   Mockenhaupt, Frank P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Ghana; Malaria; Placenta; Plasmodium falciparum; Polymorphism; Toll like receptor

Indexed keywords

PYRIMETHAMINE; TOLL LIKE RECEPTOR 1; SERINE;

ADULT; ANEMIA; ARTICLE; DRUG BLOOD LEVEL; FEMALE; GHANA; HETEROZYGOSITY; HOMOZYGOTE; HUMAN; INFECTION SENSITIVITY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PLACENTA; PREGNANCY; PREMATURE LABOR; PRIMIPARA; PRIORITY JOURNAL; PROTEIN VARIANT; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE; ADOLESCENT; AMINO ACID SUBSTITUTION; GENETIC PREDISPOSITION; GENETICS; MALARIA, FALCIPARUM; NEWBORN; PARASITOLOGY; PATHOLOGY; PREGNANCY COMPLICATIONS, PARASITIC; PREVALENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GHANA; HUMANS; INFANT, NEWBORN; MALARIA, FALCIPARUM; PLACENTA; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREVALENCE; SERINE; TOLL-LIKE RECEPTOR 1; YOUNG ADULT;

PLASMODIUM FALCIPARUM;

EID: 77954027299     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2010.05.005     Document Type: Article

References (37)

1. Abrahams V.M., Mor G. Toll-like receptors and their role in the trophoblast. Placenta 2005, 26:540-547.
2. Barreiro L.B., Ben-Ali M., Quach H., Laval G., Patin E., Pickrell J.K., Bouchier C., Tichit M., Neyrolles O., Gicquel B., Kidd J.R., Kidd K.K., Alcais A., Ragimbeau J., Pellegrini S., Abel L., Casanova J.L., Quintana-Murci L. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet. 2009, 5:e1000562.
3. Brabin B.J., Romagosa C., Abdelgalil S., Menendez C., Verhoeff F.H., McGready R., Fletcher K.A., Owens S., D'Alessandro U., Nosten F., Fischer P.R., Ordi J. The sick placenta-the role of malaria. Placenta 2004, 25:359-378.
4. Browne E.N., Frimpong E., Sievertsen J., Hagen J., Hamelmann C., Dietz K., Horstmann R.D., Burchard G.D. Malariometric update for the rainforest and savanna of Ashanti region, Ghana. Ann. Trop. Med. Parasitol. 2000, 94:15-22.
5. Coban C., Ishii K.J., Kawai T., Hemmi H., Sato S., Uematsu S., Yamamoto M., Takeuchi O., Itagaki S., Kumar N., Horii T., Akira S. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 2005, 201:19-25.
6. Duffy P.E., Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect. Immun. 2003, 71:6620-6623.
7. Finnstrom O. Studies on maturity in newborn infants. IX. Further observations on the use of external characteristics in estimating gestational age. Acta Paediatr. Scand. 1977, 66:601-604.
8. Fried M., Muga R.O., Misore A.O., Duffy P.E. Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J. Immunol. 1998, 160:2523-2530.
9. Fried M., Nosten F., Brockman A., Brabin B.J., Duffy P.E. Maternal antibodies block malaria. Nature 1998, 395:851-852.
10. Greenwood B.M., Greenwood A.M., Bradley A.K., Shenton F.C., Smith A.W., Snow R.W., Williams K., Eggelte T.A., Huikeshoven H., de Wit M. ELISA tests for dapsone and pyrimethamine and their application in a malaria chemoprophylaxis programme. Bull. World Health Organ. 1986, 64:909-916.
11. Hoebe K., Janssen E., Beutler B. The interface between innate and adaptive immunity. Nat. Immunol. 2004, 5:971-974.
12. Iwasaki A., Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010, 327:291-295.
13. Jin M.S., Kim S.E., Heo J.Y., Lee M.E., Kim H.M., Paik S.G., Lee H., Lee J.O. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007, 130:1071-1082.
14. Johnson C.M., Lyle E.A., Omueti K.O., Stepensky V.A., Yegin O., Alpsoy E., Hamann L., Schumann R.R., Tapping R.I. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J. Immunol. 2007, 178:7520-7524.
15. Kang J.Y., Nan X., Jin M.S., Youn S.J., Ryu Y.H., Mah S., Han S.H., Lee H., Paik S.G., Lee J.O. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009, 31:873-884.
16. Krishnegowda G., Hajjar A.M., Zhu J., Douglass E.J., Uematsu S., Akira S., Woods A.S., Gowda D.C. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signalling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 2005, 280:8606-8616.
17. Krutzik S.R., Ochoa M.T., Sieling P.A., Uematsu S., Ng Y.W., Legaspi A., Liu P.T., Cole S.T., Godowski P.J., Maeda Y., Sarno E.N., Norgard M.V., Brennan P.J., Akira S., Rea T.H., Modlin R.L. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat. Med. 2003, 9:525-532.
18. Kwiatkowski D.P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 2005, 77:171-192.
19. Leoratti F.M., Farias L., Alves F.P., Suarez-Mutis M.C., Coura J.R., Kalil J., Camargo E.P., Moraes S.L., Ramasawmy R. Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria. J. Infect. Dis. 2008, 198:772-780.
20. Ma X., Liu Y., Gowen B.B., Graviss E.A., Clark A.G., Musser J.M. Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS One 2007, 2:e1318.
21. Menendez C., Ordi J., Ismail M.R., Ventura P.J., Aponte J.J., Kahigwa E., Font F., Alonso P.L. The impact of placental malaria on gestational age and birth weight. J. Infect. Dis. 2000, 181:1740-1745.
22. Mockenhaupt F.P., Hamann L., von Gaertner C., Bedu-Addo G., von Kleinsorgen C., Schumann R.R., Bienzle U. Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. J. Infect. Dis. 2006, 194:184-188.
23. Mockenhaupt F.P., Cramer J.P., Hamann L., Stegemann M.S., Eckert J., Oh N.R., Otchwemah R.N., Dietz E., Ehrhardt S., Schroder N.W., Bienzle U., Schumann R.R. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:177-182.
24. Mockenhaupt F.P., Bedu-Addo G., von Gaertner C., Boye R., Fricke K., Hannibal I., Karakaya F., Schaller M., Ulmen U., Acquah P.A., Dietz E., Eggelte T.A., Bienzle U. Detection and clinical manifestation of placental malaria in southern Ghana. Malar. J. 2006, 5:119.
25. Moormann A.M., Sullivan A.D., Rochford R.A., Chensue S.W., Bock P.J., Nyirenda T., Meshnick S.R. Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J. Infect. Dis. 1999, 180:1987-1993.
26. Omueti K.O., Mazur D.J., Thompson K.S., Lyle E.A., Tapping R.I. The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components. J. Immunol. 2007, 178:6387-6394.
27. Parroche P., Lauw F.N., Goutagny N., Latz E., Monks B.G., Visintin A., Halmen K.A., Lamphier M., Olivier M., Bartholomeu D.C., Gazzinelli R.T., Golenbock D.T. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:1919-1924.
28. Schröder N.W., Schumann R.R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 2005, 5:156-164.
29. Schuring R.P., Hamann L., Faber W.R., Pahan D., Richardus J.H., Schumann R.R., Oskam L. Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions. J. Infect. Dis. 2009, 199:1816-1819.
30. Snounou G., Viriyakosol S., Zhu X.P., Jarra W., Pinheiro L., do Rosario V.E., Thaithong S., Brown K.N. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol. Biochem. Parasitol. 1993, 61:315-320.
31. Steketee R.W., Nahlen B.L., Parise M.E., Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am. J. Trop. Med. Hyg. 2001, 64:28-35.
32. Steketee R.W., Wirima J.J., Hightower A.W., Slutsker L., Heymann D.L., Breman J.G. The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. Am. J. Trop. Med. Hyg. 1996, 55:33-41.
33. Takeuchi O., Kawai T., Muhlradt P.F., Morr M., Radolf J.D., Zychlinsky A., Takeda K., Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 2001, 13:933-940.
34. Thomas D.C., Clayton D.G. Betting odds and genetic associations. J. Natl. Cancer Inst. 2004, 96:421-423.
35. WHO Global Tuberculosis Control: Epidemiology, Strategy, Financing: WHO Report 2009 2009, World Health Organization, Geneva.
36. Wurfel M.M., Gordon A.C., Holden T.D., Radella F., Strout J., Kajikawa O., Ruzinski J.T., Rona G., Black R.A., Stratton S., Jarvik G.P., Hajjar A.M., Nickerson D.A., Rieder M., Sevransky J., Maloney J.P., Moss M., Martin G., Shanholtz C., Garcia J.G., Gao L., Brower R., Barnes K.C., Walley K.R., Russell J.A., Martin T.R. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am. J. Respir. Crit. Care Med. 2008, 178:710-720.
37. Zarember K.A., Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 2002, 168:554-561.